PWP
MRK icon

Parkwoods Wealth Partners’s Merck MRK Stock Holding History

Parkwoods Wealth Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
+2,651
New +$310K 0.05% 124

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parkwoods Wealth Partners's MRK Position: Q2 2026 in Review

Parkwoods Wealth Partners opened a new position in Merck (MRK) in Q2 2026: 2,651 shares worth $341K. The stake represents 0.05% of the portfolio and ranks #124 among its holdings.

3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Parkwoods Wealth Partners held 2,651 shares of Merck worth $341K as of Q2 2026.
  • Merck was a new Parkwoods Wealth Partners position in Q2 2026.
  • Merck made up 0.05% of Parkwoods Wealth Partners's portfolio in Q2 2026, its #124 holding.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Parkwoods Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.